Breast Cancer Risk Reduction: A Patient Doctor Intervention
BreastCARE
1 other identifier
interventional
1,235
1 country
2
Brief Summary
The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer risk reduction practices. Our goal is to implement a tablet-PC (personal computer) based breast cancer risk education (BreastCare) intervention in the primary care setting that estimates a woman's individual risk for breast cancer and provides her and her physician with personalized breast cancer risk information and recommendations for action.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Jun 2011
Shorter than P25 for not_applicable breast-cancer
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 10, 2013
CompletedFirst Posted
Study publicly available on registry
April 12, 2013
CompletedResults Posted
Study results publicly available
May 16, 2013
CompletedAugust 19, 2014
August 1, 2014
1.2 years
April 10, 2013
May 15, 2013
August 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Knowledge of Breast Cancer Risk Factors
Risk knowledge was assessed using a post-survey. Participants could have scored 0-100 (with 0 meaning no correct answers, and 100 is all correct answers). This outcome was measured through a survey. Breast cancer risk knowledge was based on a series of eight questions in the survey. O
one week post-initial visit (approximately one week)
Percentage of Participants With Correct Perception of Risk
This outcome was measured through a survey. Women were asked what they thought about their risk of getting breast cancer was compared to other women of the same age.
baseline, one week post-initial visit (approximately one week)
Percentage of Participants Who Had a Discussion of Breast Cancer Risk
Self-reported discussion of breast cancer risk with physicians.
one week post-initial visit (approximately one week)
Percentage of Participants Who Reported Discussion of Mammography Screening
Self reported discussion of mammography with physician.
up to 14 months
Study Arms (2)
BreastCARE Intervention
EXPERIMENTALIntervention Clinic Patients: The RA will welcome the patient upon arrival at the clinic and again explain study procedures and field any questions. The RA will have the patient sign the HIPAA authorization form and then demonstrate how to enter information and answer questions on the tablet-PC and the patient will indicate their consent electronically before beginning the assessment. Intervention Patient Report. Once the patient completes the BreastCare Computer survey, the program will immediately generate a personal feedback report containing information about her risk factors and recommendations to reduce her risk. This report will be printed and given to the patietns before she meets with her doctor.
BreastCARE Comparison
NO INTERVENTIONPatients will be randomized into the intervention or comparison groups at the time of recruitment. Block-randomization will be used to assign patients to intervention or comparison groups. Comparison Clinic Patients. Contact and baseline interview procedures will be the same for patients from the comparison clinics, however there will be no computer assessment at the time of their clinic visit. An RA will meet the patient 10 minutes prior to her appointment time to obtain written HIPAA authorization.
Interventions
Physician Report. At the time of an individual participant's visit to her primary care physician and her completion of the assessment tool, her physician will receive a physician report. The physician report is designed to facilitate communication about breast cancer risk during the primary care visit and to provide tailored risk reduction recommendations.
Eligibility Criteria
You may qualify if:
- Patient component:
- Women who visit the General Internal Medicine (GIM) practices at SFGH and UCSF during the study period
- Between the ages of 40 and 74
- Self-identify as Asian American, Spanish- and English-speaking Latinas, African American, or White
- Have no history of breast cancer are eligible to participate.
- Physician component: Primary care physicians currently practicing at the GIM clinics at SFGH and UCSF
You may not qualify if:
- Patient component: Women whose physicians object to their participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
San Francisco General Hospital (SFGH)
San Francisco, California, 94110, United States
University of California, San Francisco Mt. Zion campus
San Francisco, California, 94143, United States
Related Publications (1)
Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Perez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP. Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial. Breast. 2015 Dec;24(6):758-66. doi: 10.1016/j.breast.2015.09.009. Epub 2015 Oct 21.
PMID: 26476466DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Celia P. Kaplan, Professor
- Organization
- University of California, San Francisco
Study Officials
- PRINCIPAL INVESTIGATOR
Celia P Kaplan, DrPH, MA
University of California, San Francisco
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2013
First Posted
April 12, 2013
Study Start
June 1, 2011
Primary Completion
August 1, 2012
Study Completion
December 1, 2012
Last Updated
August 19, 2014
Results First Posted
May 16, 2013
Record last verified: 2014-08